BABA vs BJRI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BJRI's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 1.41 and extremely low liquidity ratios (Current Ratio: 0.36, Quick Ratio: 0.21). While the company shows strong earnings surprise history and recent EPS growth of 130.8% YoY, these gains are likely driven by one-time or cyclical factors, as evidenced by negative operating margins (-0.13%) and inconsistent profitability. The stock trades at a premium to its intrinsic value and Graham number, suggesting overvaluation despite modest revenue growth. Analysts recommend 'buy' but with limited conviction, as the technical trend is bearish and insider sentiment is neutral.